WT

Warwick Tong

Amplia Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Dr Tong is a NZ trained physician with more than 30 years' experience in the Pharmaceutical and Biotechnology industry. After his early career in General Medical Practice Warwick has held a variety of roles in the pharmaceutical and biotech industry in NZ (Glaxo) Singapore (GlaxoWellcome) London (GSK), Boston (Surface Logix) and Melbourne (CTx - Cancer Therapeutics CRC). His roles have included; Medical Director, Regional Business Development Director (Asia Pacific), Commercial Strategy Director (International) and SVP Development (USA). He is a Director of Aculeus Therapeutics Pty Ltd, Clear Scientific Pty Ltd and Pacalis Therapeutics Pty Ltd. He was CEO and Director of CTx from 2011 until April 2018. Dr Tong is also a member of the Risk Committee.

Company and Roles

Company
Title
Tenure
Since
ATX
ATX
Amplia Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
8yrs, 1mthMay 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ATX
ATX
Amplia Therapeutics Limited
06/09/252,355,1401,508,933858,565N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATX
ATX
Amplia Therapeutics Limited
01/09/25
Issued
152,174$0.230$35,000Placement
ATX
ATX
Amplia Therapeutics Limited
01/09/25
Issued
336,826$0.165$55,576Issue of options
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Transfer
661,107$0.083$54,871Off-market transfer
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Issued
521,739$0.083$43,304As advised by the company
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Transfer
661,107$0.083$54,871Off-market transfer